PHILADELPHIA (April 16, 2018)—Enclara Pharmacia (Enclara), a comprehensive pharmacy benefits management (PBM) service to the hospice community, announces a strategic partnership with Medline, a medical supplies distributor and manufacturer. The strategic partnership provides Enclara E3 Mobile users the ability to order medical supplies for direct-to-patient shipping from Medline. The integration of Medline into the E3 Mobile solution represents the next phase of clinical service line integration, now providing a single point of entry that enables hospice nurses to order, track and manage pharmacy, medical supplies and durable medical equipment (DME).
“The integration of Medline within E3 Mobile provides hospices with an unrivaled platform to transform patient management, optimize workforce productivity and manage costs,” said Andy Horowitz, CEO, Enclara, via press release. “We are responding to the hospice community need to identify variances in clinical practice and cost, providing users with an expanded solution that offers increased visibility into clinical ordering. Our partnership with Medline not only meets this need, but also provides hospice organizations with a unified view of patient cost of care.”
E3 Mobile transmits orders directly to Medline fulfillment to allow for rapid direct-to-patient delivery of medical supplies, and decreased labor and delivery cost versus central supply models. The solution intends to streamline processes, optimize clinical workflow and enable hospice staff to seamlessly manage patient needs. The goal is to help save the nurse time by eliminating redundant entry, while integrating with the hospice EMR to ensure consistent patient records across systems.
“We are very excited about our strategic partnership with Enclara. Medline is committed to delivering solutions that improve quality and decrease cost for our hospice customers,” said Chris Nave, senior vice president of sales for the homecare division at Medline.
Visit enclarapharmacia.com and medline.com for more information.
